Biovie Inc. -30BIVIWPreferred / convertible
13F holders, Q4 2025 (December 31)9holders +1
1new positions
0sold out
$0.27avg. 13F price*
At the end of Q4 2025, 9 institutions reported holding Biovie Inc. -30 (BIVIW) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were Diametric Capital, LP ($203K), Warberg Asset Management LLC ($139K) and Armistice Capital, LLC ($129K).
- Company
- Biovie Inc. -30
- CUSIP
- 09074F173
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $129K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 680,793 shares bought and 108,390 shares sold, net +572,403 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Diametric Capital, LP | — | No change | 750,000 | $203K |
| Warberg Asset Management LLC | — | Add +64.1% | 461,937 | $139K |
| Armistice Capital, LLC | — | New | 500,000 | $129K |
| Prelude Capital Management, LLC | — | Reduce -36.4% | 186,621 | $48K |
| MYDA Advisors LLC | — | Reduce -0.6% | 174,000 | $45K |
| Heights Capital Management, Inc. | — | No change | 90,000 | $23K |
| Cerity Partners LLC | — | Add +0.1% | 20,112 | $5K |
| Two Sigma Securities, LLC | — | Add +2.4% | 14,038 | $4K |
| UBS Group AG | — | Reduce -57.5% | 425 | $115 |
"% of holder's portfolio" is BIVIW's weight in each manager's 13F, not the share of Biovie Inc. -30 the manager owns.